Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tessa L Holyoake

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
The Journal of Experimental Medicine|October 26, 2011
Assembling defenses against therapy-resistant leukemic stem cells: Bcl6 joins the ranksFrancesca Pellicano, Tessa L Holyoake
Blood|February 5, 2017
The chronic myeloid leukemia stem cell: stemming the tide of persistenceTessa L Holyoake, David Vetrie
Cancer Biomarkers : Section a of Disease Markers|October 6, 2007
Stem cells in chronic myeloid leukaemiaFrancesca Pellicano, Tessa L Holyoake
Hematological Oncology|April 19, 2007
Therapeutic targets in chronic myeloid leukaemiaNicholas B Heaney, Tessa L Holyoake
Immunological Reviews|December 17, 2014
Do we need more drugs for chronic myeloid leukemia?Tessa L Holyoake, G Vignir Helgason
Cancer|October 10, 2003
Prediction of initial cytogenetic response for subsequent major and complete cytogenetic response to imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemiaMark W Drummond, Tessa L Holyoake
Blood|October 26, 2013
Redirecting traffic using the XPO1 policeSheela A Abraham, Tessa L Holyoake
Experimental Hematology|December 27, 2016
Preclinical approaches in chronic myeloid leukemia: from cells to systemsCassie J Clarke, Tessa L Holyoake
Cell Cycle (Georgetown, Tex.)|September 1, 2016
Casting a NETwork instead of shooting magic bulletsSheela A Abraham, Tessa L Holyoake
Cell|September 24, 2016
Lifting the Differentiation EmbargoAnne-Louise Latif, Tessa L Holyoake
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
The Journal of Experimental Medicine|October 26, 2011
Assembling defenses against therapy-resistant leukemic stem cells: Bcl6 joins the ranksFrancesca Pellicano, Tessa L Holyoake
Blood|February 5, 2017
The chronic myeloid leukemia stem cell: stemming the tide of persistenceTessa L Holyoake, David Vetrie
Cancer Biomarkers : Section a of Disease Markers|October 6, 2007
Stem cells in chronic myeloid leukaemiaFrancesca Pellicano, Tessa L Holyoake
Hematological Oncology|April 19, 2007
Therapeutic targets in chronic myeloid leukaemiaNicholas B Heaney, Tessa L Holyoake
Immunological Reviews|December 17, 2014
Do we need more drugs for chronic myeloid leukemia?Tessa L Holyoake, G Vignir Helgason
Cancer|October 10, 2003
Prediction of initial cytogenetic response for subsequent major and complete cytogenetic response to imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemiaMark W Drummond, Tessa L Holyoake
Blood|October 26, 2013
Redirecting traffic using the XPO1 policeSheela A Abraham, Tessa L Holyoake
Experimental Hematology|December 27, 2016
Preclinical approaches in chronic myeloid leukemia: from cells to systemsCassie J Clarke, Tessa L Holyoake
Cell Cycle (Georgetown, Tex.)|September 1, 2016
Casting a NETwork instead of shooting magic bulletsSheela A Abraham, Tessa L Holyoake
Cell|September 24, 2016
Lifting the Differentiation EmbargoAnne-Louise Latif, Tessa L Holyoake
Pageof 12